FCS has a national reputation for excellence that is reflected in exceptional and compassionate patient care, innovative clinical research, cutting-edge technologies, and advanced treatments. With nearly 100 locations, FCS serves patients throughout Florida. we are committed to providing world-class cancer care in community-based settings close to home.
Lutathera® is a targeted drug therapy approved for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin. Learn More.
Discover effective treatment options for gastrointestinal stromal tumors (GIST). Learn about the latest advancements in GIST treatment and find hope for a brighter future.
Comments